Experimental therapy for lung cancer: Umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery

Current Cancer Drug Targets

Volumn 13, Issue 1, 2013, Pages 92-102

  Zhang, Xu ^a   Zhang, Leilei ^a   Xu, Wenrong ^a   Qian, Hui ^a   Ye, Shengqin ^b   Zhu, Wei ^a   Cao, Hongcui ^c   Yan, Yongmin ^a   Li, Wei ^b   Wang, Mei ^a   Wang, Wei ^d   Zhang, Ruiwen ^d  

^a JIANGSU UNIVERSITY   (China)

^b Jiangsu Center for Stem Cell Engineering and Technology   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cancer therapy; Interleukin 24; Mesenchymal stem cells; Targeted delivery

Indexed keywords

BETA ACTIN; BMI1 PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; INTERLEUKIN 24; LIPOCORTIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (4 METHOXYPHENYLACETYL) DEHYDROALANINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B BETA; PROTEIN P21; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MALE; MESENCHYMAL STEM CELL; MOUSE; NICK END LABELING; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR XENOGRAFT; UMBILICAL CORD BLOOD; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

EID: 84875854791     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800913804486665     Document Type: Article

References (41)

1. Pereboeva, L.; Komarova, S.; Mikheeva, G.; Krasnykh, V.; Curiel, D. T. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells 2003, 21 (4), 389-404.
2. Qiao, C.; Xu, W.; Zhu, W.; Hu, J.; Qian, H.; Yin, Q.; Jiang, R.; Yan, Y.; Mao, F.; Yang, H.; Wang, X.; Chen, Y. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol. Int. 2008, 32 (1), 8-15.
3. Ozawa, K.; Sato, K.; Oh, I.; Ozaki, K.; Uchibori, R.; Obara, Y.; Kikuchi, Y.; Ito, T.; Okada, T.; Urabe, M.; Mizukami, H.; Kume, A. Cell and gene therapy using mesenchymal stem cells (MSCs). J. Autoimmun. 2008, 30 (3),121-127.
4. Baksh, D.; Song, L.; Tuan, R. S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell Mol. Med. 2004, 8 (3), 301-316.
5. Studeny, M.; Marini, F. C.; Dembinski, J. L.; Zompetta, C.; Cabreira-Hansen, M.; Bekele, B. N.; Champlin, R. E.; Andreeff, M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer. Inst. 2004, 96 (21), 1593-1603.
6. Komarova, S.; Kawakami, Y.; Stoff-Khalili, M. A.; Curiel, D. T.; Pereboeva, L. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol. Cancer Ther. 2006, 5 (3), 755-766.
7. Nakamizo, A.; Marini, F.; Amano, T.; Khan, A.; Studeny, M.; Gumin, J.; Hentschel, S.; Vecil, G.; Dembinski, J.; Andreeff, M.; Lang, F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005, 65 (8), 3307-3318.
8. Elzaouk, L.; Moelling, K.; Pavlovic, J. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp. Dermatol. 2006, 15 (11), 865-874.
9. Mohr, A.; Lyons, M.; Deedigan, L.; Harte, T.; Shaw, G.; Howard, L.; Barry, F.; O'Brien, T.; Zwacka, R. Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model. J. Cell Mol. Med. 2008, 12 (6B), 2628-2643.
10. Bitsika, V.; Roubelakis, M.G.; Zagoura, D.; Trohatou, O.; Makridakis, M.; Pappa, K. I.; Marini, F. C.; Vlahou, A.; Anagnou, N. P. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev. 2012, 21 (7), 1097-1111.
11. Ghaedi, M.; Soleimani, M.; Taghvaie, N.M.; Sheikhfatollahi, M.; Azadmanesh, K.; Lotfi, A. S.; Wu, J. Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors. J. Gene. Med. 2011, 13 (3), 171-180.
12. Song, C.; Xiang, J.; Tang, J.; Hirst, D. G.; Zhou, J.; Chan, K. M.; Li, G. Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy. Hum. Gene Ther. 2011, 22 (4), 439-449.
13. Mao, W.; Zhu, X.; Tang, D.; Zhao, Y.; Zhao, B.; Ma, G.; Zhang, X.; An, G.; Li, Y. TNF-alpha Expression in the UCB-MSCs as Stable Source Inhibits Gastric Cancers Growth in Nude Mice. Cancer Invest. 2012, 30 (6), 463-472.
14. Zou, W.; Zheng, H.; He, T. C.; Chang, J.; Fu, Y. X.; Fan, W. LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. Cancer Res. 2012, 72 (12), 2980-2989
15. Hu, W.; Wang, J.; He, X.; Zhang, H.; Yu, F.; Jiang, L.; Chen, D.; Chen, J.; Dou, J. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnol. Appl. Biochem. 2011, 58 (6), 397-404.
16. Chada, S.; Sutton, R. B.; Ekmekcioglu, S.; Ellerhorst, J.; Mumm, J. B.; Leitner, W. W.; Yang, H. Y.; Sahin, A. A.; Hunt, K. K.; Fuson, K. L.; Poìndexter, N.; Roth, J. A.; Ramesh, R.; Grimm, E. A.; Mhashilkar, A. M. MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int. Immunopharmacol. 2004, 4 (5), 649-667.
17. Fisher, P.B.; Gopalkrishnan, R. V.; Chada, S.; Ramesh, R.; Grimm, E. A.; Rosenfeld, M. R.; Curiel, D. T.; Dent, P. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol. Ther. 2003, 2 (4 Suppl 1), S23-37.
18. Cunningham, C. C.; Chada, S.; Merritt, J. A.; Tong, A.; Senzer, N.; Zhang, Y.; Mhashilkar, A.; Parker, K.; Vukelja, S.; Richards, D.; Hood, J.; Coffee, K.; Nemunaitis, J. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol. Ther. 2005, 11 (1), 149-159.
19. Tong, A. W.; Nemunaitis, J.; Su, D.; Zhang, Y.; Cunningham, C.; Senzer, N.; Netto, G.; Rich, D.; Mhashilkar, A.; Parker, K.; Coffee, K.; Ramesh, R.; Ekmekcioglu, S.; Grimm, E. A.; van Wart Hood, J.; Merritt, J.; Chada, S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanomadifferentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol. Ther. 2005, 11 (1), 160-172.
20. Zhang, X.; Xu, W.; Qian, H.; Zhu, W.; Zhang, R. Mesenchymal stem cells modified to express lentivirus TNF-alpha Tumstatin(45-132) inhibit the growth of prostate cancer. J. Cell Mol. Med. 2011, 15 (2), 433-444.
21. Chan, J.; O'Donoghue, K.; de la Fuente, J.; Roberts, I. A.; Kumar, S.; Morgan, J. E.; Fisk, N. M. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 2005, 23 (1), 93-102.
22. Nakamura, K.; Ito, Y.; Kawano, Y.; Kurozumi, K.; Kobune, M.; Tsuda, H.; Bizen, A.; Honmou, O.; Niitsu, Y.; Hamada, H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004, 11 (14), 1155-1164.
23. Xin, H.; Kanehira, M.; Mizuguchi, H.; Hayakawa, T.; Kikuchi, T.; Nukiwa, T.; Saijo, Y. Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 2007, 25 (7), 1618-1626.
24. Stoff-Khalili, M. A.; Rivera, A. A.; Mathis, J. M.; Banerjee, N. S.; Moon, A. S.; Hess, A.; Rocconi, R. P.; Numnum, T. M.; Everts, M.; Chow, L. T.; Douglas, J. T.; Siegal, G. P.; Zhu, Z. B.; Bender, H. G.; Dall, P.; Stoff, A.; Pereboeva, L.; Curiel, D. T. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res. Treat. 2007, 105 (2), 157-167.
25. Ren, C.; Kumar.; Chanda, D.; Chen, J.; Mountz, J. D.; Ponnazhagan, S. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 2008, 26 (9), 2332-2338.
26. Matsuzuka, T.; Rachakatla, R. S.; Doi, C.; Maurya, D. K.; Ohta, N.; Kawabata, A.; Pyle, M. M.; Pickel, L.; Reischman, J.; Marini, F.; Troyer, D.; Tamura, M. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer 2010, 70 (1), 28-36.
27. Rachakatla, R. S.; Marini, F.; Weiss, M. L.; Tamura, M.; Troyer, D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 2007, 14 (10), 828-835.
28. Ren, C.; Kumar, S.; Chanda, D.; Kallman, L.; Chen, J.; Mountz, J. D.; Ponnazhagan, S. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther. 2008, 15 (21), 1446-1453.
29. Ling, X.; Marini, F.; Konopleva, M.; Schober, W.; Shi, Y.; Burks, J.; Clise-Dwyer, K.; Wang, R.Y.; Zhang, W.; Yuan, X.; Lu, H.; Caldwell, L.; Andreeff, M. Mesenchymal stem cells overexpressing IFN-beta inhibit breast cancer growth and metastases through stat3 signaling in a syngeneic tumor model. Cancer Microenviron. 2010, 3 (1), 83-95.
30. Tamai, H.; Miyake, K.; Yamaguchi, H.; Takatori, M.; Dan, K.; Inokuchi, K.; Shimada, T. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice. Blood 2012, 119 (1), 64-71.
31. Kucerova, L.; Altanerova, V.; Matuskova, M.; Tyciakova, S.; Altaner, C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007, 67 (13), 6304-6313.
32. Kim, S. M.; Lim, J. Y.; Park, S. I.; Jeong, C. H.; Oh, J. H.; Jeong, M.; Oh, W.; Park, S. H.; Sung, Y. C.; Jeun, S. S. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008, 68 (23), 9614-9623.
33. Nishikawa, T.; Ramesh, R.; Munshi, A.; Chada, S.; Meyn, R. E. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. Mol. Ther. 2004, 9 (6), 818-828.
34. Mhashilkar, A. M.; Stewart, A. L.; Sieger, K.; Yang, H. Y.; Khimani, A. H.; Ito, I.; Saito, Y.; Hunt, K. K.; Grimm, E. A.; Roth, J. A.; Meyn, R. E.; Ramesh, R.; Chada, S. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther. 2003, 8 (2), 207-219.
35. Gupta, P.; Emdad, L.; Lebedeva, I. V.; Sarkar, D.; Dent, P.; Curiel, D. T.; Settleman, J.; Fisher, P. B. Targeted combinatorial therapy of non-small cell lung carcinoma using a GST-fusion protein of full-length or truncated MDA-7/IL-24 with Tarceva. J. Cell Physiol. 2008, 215 (3), 827-836.
36. Yacoub, A.; Gupta, P.; Park, M. A.; Rhamani, M.; Hamed, H.; Hanna, D.; Zhang, G.; Sarkar, D.; Lebedeva, I. V.; Emdad, L.; Koumenis, C.; Curiel, D. T.; Grant, S.; Fisher, P. B.; Dent, P. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling. Mol. Cancer Ther. 2008, 7 (2), 314-329.
37. Ramesh, R.; Ito, I.; Gopalan, B.; Saito, Y.; Mhashilkar, A. M.; Chada, S. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol. Ther. 2004, 9 (4), 510-518.
38. Gopalan, B.; Litvak, A.; Sharma, S.; Mhashilkar, A. M.; Chada, S.; Ramesh, R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res. 2005, 65 (8), 3017-3024.
39. Zhao, L.; Gu, J.; Dong, A.; Zhang, Y.; Zhong, L.; He, L.; Wang, Y.; Zhang, J.; Zhang, Z.; Huiwang, J.; Qian, Q.; Qian, C.; Liu, X. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum. Gene Ther. 2005, 16 (7), 845-858.
40. Chada, S.; Mhashilkar, A. M.; Liu, Y.; Nishikawa, T.; Bocangel, D.; Zheng, M.; Vorburger, S. A.; Pataer, A.; Swisher, S. G.; Ramesh, R.; Kawase, K.; Meyn, R. E.; Hunt, K. K. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther. 2006, 13 (5), 490-502.
41. Inoue, S.; Branch, C. D.; Gallick, G. E.; Chada, S.; Ramesh, R. Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. Mol. Ther. 2005, 12 (4), 707-715.